RHYTHM PHARMACEUTICALS, INC. short interest in 2021
In 2021, RHYTHM PHARMACEUTICALS, INC.'s disclosed short interest ran from 7.95% of shares outstanding on 15 Jan 2021 to 7.75% on 31 Dec 2021, a change of -0.20 percentage points. The year's high was 9.49% on 30 Jul 2021 and its low 6.10% on 15 Mar 2021, averaging 7.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.28 days on 31 Aug 2021. Full history: RHYTHM PHARMACEUTICALS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 7.95% (15 Jan 2021)
- End of year
- 7.75% (31 Dec 2021)
- Change
- -0.20 pp
- High
- 9.49% (30 Jul 2021)
- Low
- 6.10% (15 Mar 2021)
- Average
- 7.64%
- Highest days to cover
- 19.28 (31 Aug 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 7.95% | 10.19 | |
| 29 Jan 2021 | 6.72% | 5.32 | |
| 12 Feb 2021 | 6.65% | 5.56 | results (8-K) |
| 26 Feb 2021 | 6.19% | 6.74 | |
| 15 Mar 2021 | 6.10% | 8.02 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 9.42% | 7.18 | |
| 15 Apr 2021 | 8.30% | 10.97 | |
| 30 Apr 2021 | 7.27% | 12.62 | |
| 14 May 2021 | 7.05% | 14.00 | 10-Q filed, results (8-K) |
| 28 May 2021 | 6.85% | 13.02 | |
| 15 Jun 2021 | 7.65% | 10.56 | |
| 30 Jun 2021 | 7.53% | 7.27 | |
| 15 Jul 2021 | 8.68% | 13.74 | |
| 30 Jul 2021 | 9.49% | 17.36 | |
| 13 Aug 2021 | 8.76% | 8.95 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 8.22% | 19.28 | |
| 15 Sep 2021 | 7.42% | 17.52 | |
| 30 Sep 2021 | 7.41% | 15.32 | |
| 15 Oct 2021 | 7.77% | 11.59 | |
| 29 Oct 2021 | 7.78% | 11.82 | |
| 15 Nov 2021 | 7.47% | 13.95 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 7.38% | 10.19 | |
| 15 Dec 2021 | 7.60% | 10.98 | |
| 31 Dec 2021 | 7.75% | 8.17 |
See also: RHYTHM PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.